227 related articles for article (PubMed ID: 35177038)
1. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.
Al-Jahdali H; Wali S; Albanna AS; Allehebi R; Al-Matar H; Fattouh M; Beekman M
BMC Pulm Med; 2022 Feb; 22(1):67. PubMed ID: 35177038
[TBL] [Abstract][Full Text] [Related]
2. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma.
Tran TN; Zeiger RS; Peters SP; Colice G; Newbold P; Goldman M; Chipps BE
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):37-42. PubMed ID: 26707771
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
4. PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study.
Abi Saleh W; Alameh Z; Aoun Bacha Z; Bahous J; Bou Khalil P; Chahine Z; Chami H; Dabar G; Dheiny H; Dib A; Farhat D; Irani C; Juvelekian G; Kanj N; Mansour B; Riachi M; Waked M; Yassine M; Youakim C; Zeinedine S; Zaitoun F
Allergy Asthma Clin Immunol; 2023 Sep; 19(1):80. PubMed ID: 37684679
[TBL] [Abstract][Full Text] [Related]
5. Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study.
Maspero J; Pavie J; Torres-Duque CA; Montero-Arias F; Cerino-Javier R; Rovira F; Beekman MJHI
Curr Med Res Opin; 2023 Apr; 39(4):627-638. PubMed ID: 36740960
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and disease burden of severe eosinophilic asthma in Japan.
Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
[No Abstract] [Full Text] [Related]
7. Overprescription of short-acting β
Al-Jahdali H; Wali S; Albanna AS; Al Harbi A; Allehebi R; Arwadi A; Dahan T; Fattouh M; Hamza E; Beekman M
Clin Respir J; 2022 Dec; 16(12):812-825. PubMed ID: 36279888
[TBL] [Abstract][Full Text] [Related]
8. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma.
Ko FW; Wang JKL; Hui DSC; Chan JWM; Cheung PS; Yeung YC; Sin KM; Ip MS
J Asthma Allergy; 2023; 16():173-182. PubMed ID: 36721738
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
[TBL] [Abstract][Full Text] [Related]
11. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
[TBL] [Abstract][Full Text] [Related]
12. Asthmatics with concordant eosinophilic disease classified according to their serum IgE status.
Gerday S; Schleich F; Henket M; Guissard F; Paulus V; Louis R
Respir Med Res; 2021 May; 79():100797. PubMed ID: 33383519
[TBL] [Abstract][Full Text] [Related]
13. Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Dhariwal J; Hearn AP; Kavanagh JE; d'Ancona G; Green L; Fernandes M; Thomson L; Roxas C; Kent BD; Nanzer AM; Jackson DJ
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2315-2320.e1. PubMed ID: 33689868
[TBL] [Abstract][Full Text] [Related]
14. Immunological Factors Associated with Adult Asthma in the Aseer Region, Southwestern Saudi Arabia.
Al-Ghamdi BR; Koshak EA; Omer FM; Awadalla NJ; Mahfouz AA; Ageely HM
Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31336954
[TBL] [Abstract][Full Text] [Related]
15. Breastfeeding practice and its association with respiratory symptoms and atopic disease in 1-3-year-old children in the city of Riyadh, central Saudi Arabia.
Al-Makoshi A; Al-Frayh A; Turner S; Devereux G
Breastfeed Med; 2013 Feb; 8(1):127-33. PubMed ID: 23039399
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent distribution of the atopic phenotype and allergen sensitization among asthmatic children in southern Taiwan.
Su YT; Yang YN; Li YC; Tsai CC; Chen LM; Lin YC; Niu CK; Tsai YC
Asian Pac J Allergy Immunol; 2016 Sep; 34(3):206-211. PubMed ID: 27001656
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Allergic, Eosinophilic, and Overlapping Asthma Phenotypes Among Pediatric Patients with Current Asthma: A Cross-Sectional Study from Saudi Arabia.
Asseri AA
J Asthma Allergy; 2023; 16():1297-1308. PubMed ID: 38058515
[TBL] [Abstract][Full Text] [Related]
18. A retrospective observational study on pheno-endotypes of severe asthma among adults attending asthma clinic in a tertiary care centre in India.
Talwar D; Talwar D; Jain N; Prajapat D; Pahuja S
Lung India; 2022; 39(5):393-400. PubMed ID: 36629198
[TBL] [Abstract][Full Text] [Related]
19. Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
Albers FC; Papi A; Taillé C; Bratton DJ; Bradford ES; Yancey SW; Kwon N
Respir Res; 2019 Jul; 20(1):169. PubMed ID: 31362741
[TBL] [Abstract][Full Text] [Related]
20. Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma.
Chen M; Shepard K; Yang M; Raut P; Pazwash H; Holweg CTJ; Choo E
Clin Exp Allergy; 2021 Apr; 51(4):546-555. PubMed ID: 33217063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
